Edition:
United Kingdom

IRadimed Corp (IRMD.OQ)

IRMD.OQ on NASDAQ Stock Exchange Capital Market

22.30USD
16 Jul 2018
Change (% chg)

$-0.35 (-1.55%)
Prev Close
$22.65
Open
$22.65
Day's High
$22.65
Day's Low
$21.70
Volume
9,577
Avg. Vol
9,301
52-wk High
$23.55
52-wk Low
$8.35

Latest Key Developments (Source: Significant Developments)

IRadimed Reports Q1 Non-GAAP EPS Of $0.10
Monday, 30 Apr 2018 

April 30 (Reuters) - IRadimed Corp ::IRADIMED CORPORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 NON-GAAP EARNINGS PER SHARE $0.10.Q1 GAAP EARNINGS PER SHARE $0.07.Q1 REVENUE $7.1 MILLION VERSUS $5.2 MILLION.SEES Q2 2018 NON-GAAP EARNINGS PER SHARE $0.10 TO $0.11.SEES Q2 2018 GAAP EARNINGS PER SHARE $0.07 TO $0.08.SEES Q2 2018 REVENUE $7.2 MILLION TO $7.3 MILLION.SEES FY 2018 REVENUE UNCHANGED AT $29.3 MILLION TO $30 MILLION.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $0.40 TO $0.43.SEES FY 2018 GAAP EARNINGS PER SHARE $0.30 TO $0.33 .NOW EXPECTS TO REPORT GAAP DILUTED EARNINGS PER SHARE OF $0.30 TO $0.33 FOR FY 2018.  Full Article

IRadimed Corporation Q1 GAAP Earnings Per Share $0.07
Monday, 30 Apr 2018 

April 30 (Reuters) - IRadimed Corp ::ORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 NON-GAAP EARNINGS PER SHARE $0.10.Q1 GAAP EARNINGS PER SHARE $0.07.Q1 REVENUE $7.1 MILLION VERSUS $5.2 MILLION.SEES Q2 2018 NON-GAAP EARNINGS PER SHARE $0.10 TO $0.11.SEES Q2 2018 GAAP EARNINGS PER SHARE $0.07 TO $0.08.SEES FY 2018 GAAP EARNINGS PER SHARE $0.22 TO $0.27.SEES Q2 2018 REVENUE $7.2 MILLION TO $7.3 MILLION.SEES FY 2018 REVENUE UNCHANGED AT $29.3 MILLION TO $30 MILLION.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $0.40 TO $0.43.  Full Article

Iradimed Sees Q1 2018 Non-GAAP EPS Of $0.06 To $0.07
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Iradimed Corp ::ORATION ANNOUNCES 2018 ANNUAL AND FIRST QUARTER FINANCIAL GUIDANCE.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $0.33 TO $0.38.SEES Q1 2018 NON-GAAP EARNINGS PER SHARE $0.06 TO $0.07.SEES FY 2018 GAAP EARNINGS PER SHARE $0.22 TO $0.27.SEES Q1 2018 GAAP EARNINGS PER SHARE $0.04 TO $0.05.SEES FY 2018 REVENUE $29.3 MILLION TO $30 MILLION.SEES Q1 2018 REVENUE $6.8 MILLION TO $6.9 MILLION.SEES FY 2017 REVENUE ABOUT $23.1 MILLION.  Full Article

Iradimed Corporation says Q3 GAAP earnings per share $0.02
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Iradimed Corp -:Iradimed corporation announces third quarter 2017 financial results.Q3 non-GAAP earnings per share $0.07.Q3 GAAP earnings per share $0.02.Q3 revenue $5.7 million versus $7.7 million.Sees Q4 2017 non-GAAP earnings per share $0.05 to $0.06.Raises FY 2017 non-GAAP earnings per share view to $0.17 to $0.18.Sees Q4 2017 GAAP earnings per share $0.00 to $0.02.Sees Q4 2017 revenue about $6.3 million to $6.7 million.  Full Article

Iradimed announces FDA 510(k) nod for MRI compatible patient vital signs monitor
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Iradimed Corp :Iradimed corporation announces fda 510(k) clearance of MRI compatible patient vital signs monitor.  Full Article

Iradimed Corp receives FDA clearance for MRI compatible IV infusion pump
Monday, 19 Dec 2016 

Iradimed Corp :Iradimed corporation receives fda clearance for mri compatible iv infusion pump.  Full Article

Iradimed Q2 adjusted earnings per share $0.24
Friday, 29 Jul 2016 

Iradimed Corp : Full year revenue guidance was unchanged at $39.0 million to $40.0 million . Iradimed corporation announces second quarter 2016 financial results . Sees q3 2016 non-gaap earnings per share $0.23 to $0.24 . Q2 non-gaap earnings per share $0.24 . Q2 gaap earnings per share $0.19 . Sees q3 2016 revenue about $9.9 million to $10 million . Q2 revenue rose 29.7 percent to $9.9 million . Increased its full year 2016 non-gaap earnings guidance and now expects non-gaap diluted earnings per share of $0.91 to $0.93 for 2016 .Fy2016 earnings per share view $0.89, revenue view $39.2 million -- Thomson Reuters I/B/E/S.  Full Article